{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:40:22Z","timestamp":1777948822117,"version":"3.51.4"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,3]]},"DOI":"10.7759\/cureus.108173","type":"journal-article","created":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T20:57:46Z","timestamp":1777841866000},"source":"Crossref","is-referenced-by-count":0,"title":["Discoid Lupus Erythematosus Successfully Treated With Anifrolumab"],"prefix":"10.7759","author":[{"given":"Jake","family":"Breimann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shayan","family":"Waseh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002954.pub3","article-title":"Drugs for discoid lupus erythematosus","volume":"5","author":"Jessop S","year":"2017","unstructured":"Jessop S, Whitelaw DA, Grainge MJ, Jayasekera P. Drugs for discoid lupus erythematosus. Cochrane Database Syst Rev. 2017, 5:CD002954. 10.1002\/14651858.CD002954.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13709","article-title":"Illness perception in association with psychological functioning in patients with discoid lupus erythematosus","volume":"173","author":"Chen P","year":"2015","unstructured":"Chen P, Broadbent E, Coomarasamy C, Jarrett P. Illness perception in association with psychological functioning in patients with discoid lupus erythematosus. Br J Dermatol. 2015, 173:824-6. 10.1111\/bjd.13709","journal-title":"Br J Dermatol"},{"key":"ref3","unstructured":"DailyMed - SAPHNELO- anifrolumab injection, solution. (2025). Accessed. April 17, 2025: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=d6203302-2128-41a7-b0b4-0e6c0704d4dc."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.0175","article-title":"Assessment of clinical response to anifrolumab in patients with refractory discoid lupus erythematosus","volume":"159","author":"Shaw K","year":"2023","unstructured":"Shaw K, Sanchez-Melendez S, Taylor D, Barker J, LaChance A, Shahriari N, Vleugels RA. Assessment of clinical response to anifrolumab in patients with refractory discoid lupus erythematosus. JAMA Dermatol. 2023, 159:560-3. 10.1001\/jamadermatol.2023.0175","journal-title":"JAMA Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2023-001007","article-title":"Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE","volume":"10","author":"Bao A","year":"2023","unstructured":"Bao A, Petri MA, Fava A, Kang J. Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE. Lupus Sci Med. 2023, 10:10.1136\/lupus-2023-001007","journal-title":"Lupus Sci Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2009.06.013","article-title":"Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage","volume":"214","author":"Vermi W","year":"2009","unstructured":"Vermi W, Lonardi S, Morassi M, et al.. Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage. Immunobiology. 2009, 214:877-86. 10.1016\/j.imbio.2009.06.013","journal-title":"Immunobiology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10479.x","article-title":"Interferon-\u03b1 stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus","volume":"165","author":"Zahn S","year":"2011","unstructured":"Zahn S, Rehk\u00e4mper C, Ferring-Schmitt S, Bieber T, T\u00fcting T, Wenzel J. Interferon-\u03b1 stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus. Br J Dermatol. 2011, 165:1118-23. 10.1111\/j.1365-2133.2011.10479.x","journal-title":"Br J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/387948-discoid-lupus-erythematosus-successfully-treated-with-anifrolumab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T20:57:47Z","timestamp":1777841867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/387948-discoid-lupus-erythematosus-successfully-treated-with-anifrolumab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,3]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.108173","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,3]]}}}